The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     
Please sign up for SocialPicks site access - it's free!

Biotech Stock to watch: Exelixis, Inc (EXEL)

 Dec 12, 2008 06:10 PM UTC
Return Risk
-72.15% MID
Tracked Blogger
Symbol Sentiment Start Return Closed
BMY n/a
EXEL n/a
IND n/a

Graphic_arrow1 Via The StockMasters - Investing News and Analysis, Hot Stock Tips, Stock Market commentary for the Savvy Investor:  


This company Exelixis is colloborating with BMY on a cancer drug that's getting Cancer Cellspositive FDA data, here is the press release:



SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (Nasdaq:EXEL) today announced that Bristol-Myers Squibb Company (NYSE:BMY) has exercised its option to develop and commercialize Exelixis' investigational new drug (IND) candidate XL413, a selective inhibitor of Cdc7.


read more


 Graphic_website1 Read the rest of original post »



Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment



IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch